We help companies connect strategy to execution.

Muller Advisory identifies adoption risk, designs the commercial architecture required to address it, and can remain embedded to lead execution when clients need experienced fractional leadership.

Our Services

Adoption Readiness™ Diagnostic

A structured evaluation of clinical, commercial, and financial readiness supported by the /45 Adoption Readiness™ Score, a commercial risk map, and prioritized recommendations.

Commercial Architecture & Strategy

Translate diagnostic findings into positioning, stakeholder strategy, market access priorities, sales enablement, operating decisions, and a sequenced commercialization roadmap.

Fractional Commercial Leadership

Embedded Fractional CMO or Commercial COO leadership to guide execution, align teams and specialists, establish operating cadence, and maintain accountability against defined priorities and milestones.

OUR Audiences

Founders and commercial teams encounter different adoption risks as they move from clinical promise to sustained utilization. Muller Advisory applies a diagnostic-to-execution model to identify where adoption could break, establish the commercial priorities, and provide embedded leadership when additional execution capacity is needed.

Adoption Readiness™ Diagnostic

Evaluates readiness across the Clinical, Commercial, and Financial layers, producing the /45 Adoption Readiness™ Score, a commercial risk map, and prioritized recommendations.

BEST FOR

Companies preparing for launch, a financing round, a board meeting, or a post-pilot reassessment.

Fractional Commercial Leadership

Embedded Fractional CMO or Commercial COO leadership to guide execution, establish operating discipline, align teams and specialists, and maintain accountability against priorities and milestones.

BEST FOR

Companies that need sustained senior commercial leadership without immediately adding a full-time executive.

Commercial Architecture & Strategy

Translates diagnostic findings into positioning, stakeholder strategy, market access priorities, sales enablement, and a sequenced commercialization roadmap.

BEST FOR

Teams that need to address a defined commercialization constraint or prepare the organization for its next stage of growth.

Investors and boards evaluate adoption risk on a different timeline before an investment, during portfolio planning, or as a company approaches a critical commercial decision. Muller Advisory provides an independent view of commercialization readiness using the same MedTech Adoption Architecture™ applied with operating teams.

Adoption Readiness™ Diligence

An independent evaluation of a target or portfolio company’s commercialization readiness, delivered on investment-committee timelines. Findings provide a structured view of where adoption risk is concentrated before capital is committed.

BEST FOR

Investors evaluating a specific MedTech opportunity or preparing for an investment decision.

Board & Portfolio Company Diagnostic

A board-ready assessment supported by the /45 Adoption Readiness™ Score, a commercial risk map, and prioritized recommendations for leadership attention.

BEST FOR

Boards and investors assessing whether a portfolio company is prepared for launch, scale, or additional capital.

Ongoing Portfolio Advisory

Recurring executive advisory for investors, boards, and portfolio-company leadership to monitor adoption priorities, evaluate progress, and support critical commercialization decisions.

BEST FOR

Funds and boards that need sustained commercialization judgment across one or more portfolio companies.

A raise, a launch, a stalled rollout, 
a board deadline, or a portfolio review?

Let's Talk